GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cell MedX Corp (OTCPK:CMXC) » Definitions » E10

Cell MedX (Cell MedX) E10 : $-0.04 (As of Feb. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Cell MedX E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Cell MedX's adjusted earnings per share data for the three months ended in Feb. 2024 was $0.001. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.04 for the trailing ten years ended in Feb. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-08), Cell MedX's current stock price is $0.031. Cell MedX's E10 for the quarter that ended in Feb. 2024 was $-0.04. Cell MedX's Shiller PE Ratio of today is .


Cell MedX E10 Historical Data

The historical data trend for Cell MedX's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cell MedX E10 Chart

Cell MedX Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cell MedX Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 - -0.04 -0.04 -0.04

Competitive Comparison of Cell MedX's E10

For the Medical Devices subindustry, Cell MedX's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cell MedX's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cell MedX's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cell MedX's Shiller PE Ratio falls into.



Cell MedX E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cell MedX's adjusted earnings per share data for the three months ended in Feb. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Feb. 2024 (Change)*Current CPI (Feb. 2024)
=0.001/129.4194*129.4194
=0.001

Current CPI (Feb. 2024) = 129.4194.

Cell MedX Quarterly Data

per share eps CPI Adj_EPS
201405 0.000 100.373 0.000
201408 -0.002 100.352 -0.003
201411 -0.010 99.635 -0.013
201502 -0.010 99.032 -0.013
201505 -0.010 100.333 -0.013
201508 -0.030 100.548 -0.039
201511 -0.020 100.135 -0.026
201602 -0.010 100.040 -0.013
201605 -0.010 101.355 -0.013
201608 -0.010 101.617 -0.013
201611 -0.030 101.829 -0.038
201702 -0.010 102.779 -0.013
201705 0.020 103.256 0.025
201708 -0.020 103.587 -0.025
201711 -0.004 104.072 -0.005
201802 -0.010 105.052 -0.012
201805 -0.010 106.148 -0.012
201808 -0.010 106.383 -0.012
201811 -0.003 106.338 -0.004
201902 -0.010 106.649 -0.012
201905 0.000 108.048 0.000
201908 -0.010 108.245 -0.012
201911 -0.010 108.519 -0.012
202002 -0.010 109.139 -0.012
202005 0.000 108.175 0.000
202008 -0.004 109.662 -0.005
202011 -0.003 109.793 -0.004
202102 -0.003 110.968 -0.003
202105 -0.010 113.576 -0.011
202108 -0.004 115.421 -0.004
202111 -0.003 117.269 -0.003
202202 -0.002 119.703 -0.002
202205 0.000 123.323 0.000
202208 -0.002 124.958 -0.002
202211 -0.002 125.607 -0.002
202302 -0.002 126.928 -0.002
202305 0.000 128.314 0.000
202308 -0.001 129.538 -0.001
202311 -0.001 129.548 -0.001
202402 0.001 129.419 0.001

Add all the adjusted EPS together and divide 10 will get our e10.


Cell MedX  (OTCPK:CMXC) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Cell MedX E10 Related Terms

Thank you for viewing the detailed overview of Cell MedX's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Cell MedX (Cell MedX) Business Description

Traded in Other Exchanges
N/A
Address
123 W. Nye Lane, Suite 446, Carson City, NV, USA, 89706
Cell MedX Corp is an early stage development company focused on the discovery, development and, commercialization of therapeutic products for patients with diseases such as diabetes, by developing technologies to help manage the illness and related complications. The company's product portfolio consists of electromedical technologies, ebalance, and others.
Executives
Richard Jeffs 10 percent owner FLAT 7, 6 ENNISMORE GARDENS, LONDON X0 SW7 1NL
Dwayne Yaretz director, officer: Chief Executive Officer SUITE 1050 WEST PENDER STREET SUITE 2250, VANCOUVER A1 V6E 3S7
Bradley S Hargreaves 10 percent owner 904-1616 BAYSHORE DR, VANCOUVER A1 V6G3L1
Frank Mcenulty director, officer: CEO, CFO, Treas., Sec 4182 N. VIKING WAY, SUITE 216, LONG BEACH CA 90808-1475
Joao Dacosta director, officer: COO #810 - 789 WEST PENDER STREET, VANCOUVER A1 V6C 1H2
George Adams director 7535 CONSERVATION ROAD, GUELPH A6 N1H6J1
Terrance George Owen director, officer: CEO 635 FOURTH LINE (UNIT 1), OAKVILLE A6 L6L 5BO
John David Sanderson officer: Chief Medical Officer 9 ISLANDVIEW, IRVINE CA 92604
Yanika S Silina officer: CFO, Treasurer and Secretary 789 WEST PENDER STREET, UNIT 810, VANCOUVER A1 V6C 1H2
Jean M Arnett 10 percent owner 121 - 3989 HENNING DRIVE, BURNABY A1 V5C 6P8
Ean Kremer director, officer: Chief Technology Officer C/O PLANDEL RESOURCES, INC., 4575 DEAN MARTIN DRIVE, STE. 2206, LAS VEGAS NV 89103

Cell MedX (Cell MedX) Headlines

From GuruFocus

Cell MedX Insider Buys 22,500 Shares

By Kyle Ferguson Kyle Ferguson 11-11-2016